The challenges of clinical trials, particularly those testing Alzheimer’s disease drugs, was the focus of an hour-long panel discussion on Friday. The event was hosted by the Forum at Harvard T.H. Chan School of Public Health, in collaboration with STAT.
The program was presented in partnership with HHMI Tangled Bank Studios and in association with NOVA, whose film “Can Alzheimer’s Be Stopped?” examines the hurdles to developing and testing experimental treatments for the disease.
Missed the event live? The video is available in its entirety below.
About the Author Reprints
